Pegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical)

培非格司亭生物仿类似药(江苏奥赛康)

Report date: 2026/05/27 10:23:25

Base Information

Drug NamePegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical)
Drug Alias Name培非格司亭生物仿仿制药(江苏奥赛康)非格司亭生物类似药(江苏奥赛康)聚乙二醇化重组人粒细胞刺激因子(江苏奥赛康)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A